Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | President and CEO | March 31, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Unit - 10SEC Table II · derivative / convertible security · Expires 2028-03-31 | Direct | 16,448 |
Reported balance
After 2026-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-31 · Disposition to issuer · Disposed 8,211 · Balance 16,448 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2: Forfeited shares were due to vest on June 15, 2028. F3: Shares were deemed expired on March 31, 2026 |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock
F2: Forfeited shares were due to vest on June 15, 2028.
F3: Shares were deemed expired on March 31, 2026
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 2, 2022 17:30 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 4,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000040 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 18:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,756 | $188.22 | $330,521.34 |
DisclosureSEC source: 0001228924-22-000021 · primary_doc.xml · nonDerivative · entry 4 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,640 F7 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 18:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 4,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000021 · primary_doc.xml · nonDerivative · entry 3 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,396 F5 · shares: Shares represent common stock of Mesa Labs issued upon release of performance share units issued under the FY20-FY22 performance share unit program Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000021 · primary_doc.xml · derivative · entry 6 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 684 Underlying: Common Stock · 685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000021 · primary_doc.xml · derivative · entry 5 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents the contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2020 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 740 | $185.57 | $137,321.80 |
DisclosureSEC source: 0001228924-22-000021 · primary_doc.xml · nonDerivative · entry 2 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,341 F6 · shares: Represents shares of common stock received by Mesa Labs for tax withholding purposes in connection with the net-settlement of the issuance of shares of common stock in respect to the vested RSUs Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 18:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000021 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:33 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 16,353 | $0.00 Strike: $185.57 | $0.00 |
DisclosureSEC source: 0001228924-22-000015 · primary_doc.xml · derivative · entry 2 Owens Gary M · CIK 0001700671 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,873 Underlying: Common Stock · 16,353 shares Expires 2028-06-15 F4 · derivative.exercise_date: 1/3 exercisable on each of June 15, 2023, 2024 and 2025 Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 20:33 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 7 · Derivative | 6,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000015 · primary_doc.xml · derivative · entry 1 Owens Gary M · CIK 0001700671 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,968 Underlying: Common Stock · 6,968 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents the right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on each of June 15, 2023, 2024 and 2025 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 22:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 15,786 | $0.00 Strike: $268.85 | $0.00 |
DisclosureSEC source: 0001228924-21-000068 · primary_doc.xml · derivative · entry 3 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,520 Underlying: Common Stock · 15,786 shares Expires 2027-09-01 F6 · derivative.exercise_date: NSOs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and June 15, 2024 Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 22:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 6 · Derivative | 4,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000068 · primary_doc.xml · derivative · entry 2 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,025 Underlying: Common Stock · 4,025 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F5 · shares: RSUs granted for navigation of Company through Covid-19 F4 · derivative.exercise_date: RSUs that cliff vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 22:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 5 · Derivative | 4,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000068 · primary_doc.xml · derivative · entry 1 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,917 Underlying: Common Stock · 4,917 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on September 1, 2022, 1/3 on June 15, 2023 and 1/3 on June 15, 2024 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 16:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 6,545 | $255.67 | $1,673,360.15 |
DisclosureSEC source: 0001228924-21-000040 · primary_doc.xml · nonDerivative · entry 2 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,396 F2 · shares: Shares sold to cover taxes associated with Performance Share Units Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 4 · Derivative | 1,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · derivative · entry 7 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,831 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F5 · derivative.exercise_date: RSUs granted for 15% salary reduction for the twelve months ended May 31, 2021 and 60% of cash bonus target for Fiscal Year 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 706 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · derivative · entry 6 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,369 Underlying: Common Stock · 706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vest 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 2 · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · derivative · entry 5 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2020 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 1,557 | $263.30 | $409,958.10 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · nonDerivative · entry 4 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,493 Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · nonDerivative · entry 3 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 706 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · nonDerivative · entry 2 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 20:55 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000035 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 16:25 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 14,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000040 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,941 F1 · shares: Shares represent common stock of Mesa Labs issued upon release of performance share units that were issued under the FY2019-FY2021 performance share unit program Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 15:12 UTC | MESA LABORATORIES INC /CO/ mlab · Entity 5221 | SaleCommon Stock | 1,350 | $264.00 | $356,400.00 |
DisclosureSEC source: 0001228924-21-000024 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,513 F1 · shares: Shares sold to cover tax liability associated with vesting of RSAs granted in March 2017 Read SEC document |
| October 08, 2020 Filed Oct 9, 2020 22:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 323 | $276.91 | $89,441.93 |
DisclosureSEC source: 0001228924-20-000028 · primary_doc.xml · nonDerivative · entry 2 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,863 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 23, 2020 Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 22:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 677 | $275.00 | $186,175.00 |
DisclosureSEC source: 0001228924-20-000028 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,186 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on June 23, 2020 Read SEC document |
| October 06, 2020 Filed Oct 6, 2020 22:35 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,000 | $265.00 | $265,000.00 |
DisclosureSEC source: 0001228924-20-000027 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,863 F1 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23,2020 Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 100 | $249.32 | $24,932.00 |
DisclosureSEC source: 0001437749-20-019839 · rdgdoc.xml · nonDerivative · entry 3 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,863 F5 · kind: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 23, 2020 Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019839 · rdgdoc.xml · derivative · entry 4 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingency to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/3 on September 15, 2018 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 757 | $246.48 | $186,585.36 |
DisclosureSEC source: 0001437749-20-019839 · rdgdoc.xml · nonDerivative · entry 2 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,963 F4 · shares: Represents shares of common stock retained by Mesa Labs for tax withholding purposes in connection with the net-settlement on the issuance of shares of common stock in respect to vested RSUs Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 20:31 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019839 · rdgdoc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 4 · Derivative | 1,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000017 · primary_doc.xml · derivative · entry 6 Owens Gary M · CIK 0001700671 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,831 Underlying: Common Stock · 1,831 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F7 · shares: RSUs granted for 15% salary reduction for next 12 months and conversion of 60% of cash bonus target for Fiscal Year 21. F8 · derivative.exercise_date: RSUs that cliff vest on June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Options · Derivative | 13,795 | $0.00 Strike: $226.72 | $0.00 |
DisclosureSEC source: 0001228924-20-000017 · primary_doc.xml · derivative · entry 5 Owens Gary M · CIK 0001700671 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,734 Underlying: Common Stock · 13,795 shares Expires 2026-06-15 F6 · derivative.exercise_date: NSOs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 2,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000017 · primary_doc.xml · derivative · entry 4 Owens Gary M · CIK 0001700671 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,075 Underlying: Common Stock · 2,075 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F5 · derivative.exercise_date: RSUs that vest approximately 1/3 on June 15, 2021 and each of the next two anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000017 · primary_doc.xml · derivative · entry 3 Owens Gary M · CIK 0001700671 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2020 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Tax withholdingCommon Stock | 440 | $226.72 | $99,756.80 |
DisclosureSEC source: 0001228924-20-000017 · primary_doc.xml · nonDerivative · entry 2 Owens Gary M · CIK 0001700671 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F4 · shares: Represents shares of common stock retained by Mesa Labs for tax withholding purposes in connection with the net-settlement on the issuance of shares of common stock in respect to the vested RSUs. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:59 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000017 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2019 Filed Sep 19, 2019 14:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 1 · Derivative | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000038 · primary_doc.xml · derivative · entry 2 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,720 Underlying: Common Stock · 1,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/3 on September 15, 2019, 1/3 on September 15, 202 and 1/3 on September 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 16, 2019 Filed Sep 19, 2019 14:05 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000038 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Represents stock from an RSU that vested on September 15, 2019. No shares were sold by the reporting person in connection with this transaction Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 14:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 2 · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000022 · primary_doc.xml · derivative · entry 4 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: Restricted stock units that vest 1,000 shares on each of the first five anniversary dates from grant F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 10, 2019 Filed Jun 13, 2019 18:11 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Option · Derivative | 9,939 | $0.00 Strike: $203.54 | $0.00 |
DisclosureSEC source: 0001228924-19-000019 · primary_doc.xml · derivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,939 Underlying: Common Stock · 9,939 shares Expires 2025-06-10 F1 · derivative.exercise_date: 1/4 exercisable on each of the next four anniversary dates Read SEC document |
| September 15, 2018 Filed Jun 17, 2019 14:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit -1 · Derivative | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000022 · primary_doc.xml · derivative · entry 3 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,440 Underlying: Common Stock · 1,720 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted stock units that vest 1/3 on September 15, 2019, 1/3 on September 15, 2020 and 1/3 on September 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| September 15, 2018 Filed Jun 17, 2019 14:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000022 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 6, 2018 17:54 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock | 5,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-18-000020 · primary_doc.xml · nonDerivative · entry 1 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,160 F1 · shares: Restricted Stock Award that vests 1/3 on September 15, 2018 and 1/3 on each of the next two anniversary dates. Read SEC document |
| June 05, 2018 Filed Jun 17, 2019 14:04 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 1 · Derivative | 5,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000022 · primary_doc.xml · derivative · entry 2 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,160 Underlying: Common Stock · 5,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted stock units that vest 1/3 on September 15, 2019, 1/3 on September 15, 2020 and 1/3 on September 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 15:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon-Qualified Stock Option · Derivative | 5,000 | $0.00 Strike: $142.40 | $0.00 |
DisclosureSEC source: 0001228924-18-000010 · primary_doc.xml · derivative · entry 1 Owens Gary M · CIK 0001700671 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 5,000 shares Expires 2024-04-02 F1 · derivative.exercise_date: 20% exercisable on each of first 5 anniversary dates Read SEC document |
| September 01, 2017 Filed Sep 1, 2017 21:26 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantNon Qualified Stock Option · Derivative | 2,000 | $0.00 Strike: $136.42 | $0.00 |
DisclosureSEC source: 0001228924-17-000040 · primary_doc.xml · derivative · entry 1 Owens Gary M · CIK 0001700671 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 2,000 shares Expires 2023-09-01 F1 · derivative.exercise_date: 20% exercisable on each of first five anniversary date Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.